tirzepatide cardiovascular outcomes trial results august 2025 event risk assessment: a pre-specified meta-analysis Effects of tirzepatide on circulatory

For most people, yes

However, these side effects were mild to moderate and usually resolved within a few days

Goodwin The Supreme Court and Political Question: Affirmation or Abdication

Triple-Hormone-Receptor Agonist Retatrutide for Obesity Weekly retatrutide injections (1 mg12 mg) resulted in weight reductions of 7.217.5% at 24 weeks and 8.724.2% at 48 weeks in subjects with overweight or obesity (without T2DM) in a phase II, double-blind, randomized, placebo-controlled [125]

Cevimeline is another prescription sialagogue that works through a similar mechanism but with potentially fewer cardiovascular side effects than pilocarpine